Hepatology
Experts in the development and management of all aspects of MASH/MASLD, and viral hepatitis clinical trials
The voice of MASH investigators
Global survey provides insights for trial operations
Metabolic dysfunction-associated steatohepatitis (MASH), a component of metabolic syndrome, is an area of very active clinical development. To help determine the impact of this competitive environment for available and qualified site resources, as well as eligible patients, ÃÛÌÒ´«Ã½ undertook a global survey of MASH clinical trial sites across 37 different countries.
Digital solutions to alleviate MASH clinical trial challenges
The performance of MASH clinical trials presents many challenges unique to the field. Watch the on-demand webinar to learn about:
- The ability for digital technologies MRI, MRE and whole slide imaging to address MASH clinical trial challenges
- The ability of MRI and MRE to provide timely, high quality non-invasive solutions to enrolment
- The ability of whole slide imaging to facilitate rapid complex workflows that assure consistent high quality assessments of primary efficacy endpoints by enabling expert histopathologists to interact remotely and in real time.
Helping MASH study sites to succeed
Get insights and feedback from our extensive MASH study experience, and the findings from ÃÛÌÒ´«Ã½¡¯s survey of more than 2,000 sites across 30 countries including:
- How to best support global MASH sites to succeed in a competitive environment
- Optimising the operational strength of study sites to collectively support the MASH pipeline
- How understanding global and regional nuances can enhance MASH site patient recruitment and operational strategy
Metabolic dysfunction-associated steatohepatitis (MASH) clinical trials
Join Andrew Roche, PhD, a senior member of ÃÛÌÒ´«Ã½'s MASH team, as he speaks about overcoming the challenges and considerations associated with MASH Clinical Trials and examination of potential strategies to address during trial design or study execution.
Blogs and media contributions
-
.jpeg?crop=yes&w=545&h=286&itok=2q4eoj4I "obesity scan person")
Press release: Global ÃÛÌÒ´«Ã½ survey shows need for more efficient obesity clinical trial design
ÃÛÌÒ´«Ã½ plc today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities.
-
Blog: Obesity-related liver conditions: Understanding treatment options
Explore obesity¡¯s role in liver disease progression and the value of different treatment options providing renewed hope to patients.
.jpeg?crop=yes&w=2048&h=1077&a=0,88&itok=8muE9F2Q "obesity scan person"){kind=icon}
Hepatology solutions
Discover more about ÃÛÌÒ´«Ã½'s solutions in the development and management of all aspects of MASH/MASLD, and viral hepatitis clinical trials clinical trials experts.